Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Mario Ernest
Relationship:   Director
City:   Redwood City
State:   CA
   
Insider Summary:
  
   
Companies Owned :   13    
Direct Shares   1,151,697    

Indirect Shares

   265,510      
Direct Value   $8,420,214    

Indirect Value

   $116,216      
Total Shares   1,417,207      
Total Value   $8,536,430      


Maxygen Inc $0 Ardea Biosciences Inc $0 Boston Scientific Corp $6,501,438 Alexza Pharmaceuticals Inc. $0 Vivus Inc $9,524 Xenoport Inc $0 Chimerix Inc $12,477 Kindred Biosciences, Inc. $1,563,250 Soleno Therapeutics Inc $29,925 Eyenovia Inc $303,600 Maxygen Inc $0 Ardea Biosciences Inc $0 Boston Scientific Corp $6,501,438 Alexza Pharmaceuticals Inc. $0 Vivus Inc $9,524 Xenoport Inc $0 Chimerix Inc $12,477 Kindred Biosciences, Inc. $1,563,250 Soleno Therapeutics Inc $29,925 Eyenovia Inc $303,600
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    3   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    2   
    0    
   
     Gain/Loss Ratio :
   0.0   
   0.0   
     Percentage Gain/Loss :
   -41.7%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Maxygen Inc MAXY Director 2012-06-06 62,964 2003-08-05 0    Premium*  
            Ardea Biosciences Inc RDEA Director 2004-05-05 70,431 2004-05-05 85,554    Premium*  
            Pharmaceutical Product Developme... PPDI Director 2011-12-05 0 2011-12-05 0    Premium*  
            Boston Scientific Corp BSX Director 2015-11-16 86,032 2013-11-08 0    Premium*  
            Alexza Pharmaceuticals Inc. ALXA Director 2006-03-08 18,181 0    Premium*  
            Celgene Corp CELG 2019-11-20 0 2019-11-20 0    Premium*  
            Vivus Inc VVUS Director 2013-05-29 81,125 2012-04-25 0    Premium*  
            Xenoport Inc XNPT Director 2015-05-19 88,750 2012-08-09 0    Premium*  
            Tonix Pharmaceuticals Holding Corp TNXP Director 2018-02-09 0 2018-06-25 50,000    Premium*  
            Chimerix Inc CMRX Director 2018-05-18 12,905 2018-05-18 108,167    Premium*  
            Kindred Biosciences, Inc. KIN Director 2018-10-29 169,000 2013-12-12 0    Premium*  
            Soleno Therapeutics Inc SLNO 2024-05-21 186,566 2024-05-21 21,789    Premium*  
            Eyenovia Inc EYEN Director 2021-01-15 375,743 2018-07-24 0    Premium*  
* Premium Members only  

Records found :    373         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 15
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
BSX Boston Scientific Corp Director   –       •      –    2009-05-06 4 B $8.49 $424,650 D/D 50,000 71,004 2.39 -
BSX Boston Scientific Corp Director   –       •      –    2010-11-04 4 B $6.44 $64,393 D/D 10,000 81,004 2.39 -
BSX Boston Scientific Corp Director   –       •      –    2011-02-07 4 B $6.94 $346,990 D/D 50,000 131,004 2.39 -
BSX Boston Scientific Corp Director   –       •      –    2011-05-13 4 B $6.72 $14,972 I/I 2,228 22,228 2.1 -
BSX Boston Scientific Corp Director   –       •      –    2011-05-17 4 B $6.72 $1,828 I/I 272 22,500 2.02 -
BSX Boston Scientific Corp Director   –       •      –    2011-08-02 4 B $6.82 $682,230 D/D 100,000 231,004 2.39 -
BSX Boston Scientific Corp Director   –       •      –    2011-08-03 4 B $6.70 $670 I/I 100 22,600 2.02 -
BSX Boston Scientific Corp Director   –       •      –    2011-10-25 4 B $5.50 $137,500 D/D 25,000 256,004 2.39 -
BSX Boston Scientific Corp Director   –       •      –    2011-11-21 4 B $5.30 $132,500 D/D 25,000 306,004 2.39 -
BSX Boston Scientific Corp Director   –       •      –    2011-11-28 4 B $5.40 $540,000 D/D 100,000 407,304 2.39 -
BSX Boston Scientific Corp Director   –       •      –    2012-02-21 4 B $6.12 $122,400 D/D 20,000 427,304 2.39 -
BSX Boston Scientific Corp Director   –       •      –    2012-02-23 4 B $5.91 $59,100 D/D 10,000 447,304 2.39 -
BSX Boston Scientific Corp Director   •       •      –    2012-08-06 4 B $5.29 $169,280 D/D 32,000 479,304 2.39 -
BSX Boston Scientific Corp Director   •       •      –    2013-05-06 4 B $7.76 $232,800 D/D 30,000 509,304 2.39 -
BSX Boston Scientific Corp Director   •       •      –    2013-11-08 4 S $11.73 $239,857 I/I (20,445) 0 0 -
BSX Boston Scientific Corp Director   •       •      –    2013-11-08 4 S $11.73 $1,351,503 D/D (115,200) 394,959 0 -
BSX Boston Scientific Corp Director   •       •      –    2013-12-26 4 AS $12.06 $120,600 D/D (10,000) 384,959 0 -
BSX Boston Scientific Corp Director   •       •      –    2014-01-06 4 AS $12.50 $125,000 D/D (10,000) 374,959 0 -
BSX Boston Scientific Corp Director   •       •      –    2014-02-03 4 AS $13.19 $131,884 D/D (10,000) 364,959 0 -
BSX Boston Scientific Corp Director   •       •      –    2014-02-06 4 S $12.80 $218,935 D/D (17,104) 347,855 0 -
BSX Boston Scientific Corp Director   •       •      –    2014-03-03 4 AS $12.98 $129,755 D/D (10,000) 337,855 0 -
BSX Boston Scientific Corp Director   •       •      –    2014-04-01 4 AS $13.55 $135,527 D/D (10,000) 327,855 0 -
BSX Boston Scientific Corp Director   •       •      –    2014-05-01 4 AS $12.58 $125,836 D/D (10,000) 317,855 0 -
BSX Boston Scientific Corp Director   •       •      –    2014-06-02 4 AS $12.88 $128,790 D/D (10,000) 307,855 0 -
BSX Boston Scientific Corp Director   •       •      –    2014-07-01 4 AS $12.95 $129,468 D/D (10,000) 297,855 0 -
  373  Records found
  1   2  3   4   5   6   7   8   9   10   11   12   13   14   15      
  Page 2 of 15  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us